Alkermes, Cephalon and Vivitrex#174;: Pioneering the Alcohol Dependence Market
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 62 (Table of Contents)
Published: 1 Aug-2005
DOI: 10.3833/pdr.v2005.i62.638 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Alkermes has chosen Cephalon as the US partner for Vivitrex#174;, its sustained-release version of naltrexone that it awaiting approval by the US FDA for the treatment of alcohol dependence...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS